Finance

Lists
600329:SHA
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CNÂ¥36.16
-0.03%
(-0.0100) 1D
Aug 17, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600329...
Open
CNÂ¥35.60
High
CNÂ¥36.17
Low
CNÂ¥35.12
Mkt. cap
24.19B
Avg. vol.
4.41M
Volume
3.73M
Dividend
13.25%
Quarterly dividend
CNÂ¥1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
12.79
52-wk high
CNÂ¥50.97
52-wk low
CNÂ¥34.70
EPS
CNÂ¥2.83
Shares outstanding
568.87M
No. of employees
4K
Open
CNÂ¥35.60
High
CNÂ¥36.17
Low
CNÂ¥35.12
Mkt. cap
24.19B
Avg. vol.
4.41M
Volume
3.73M
Dividend
13.25%
Quarterly dividend
CNÂ¥1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
12.79
52-wk high
CNÂ¥50.97
52-wk low
CNÂ¥34.70
EPS
CNÂ¥2.83
Shares outstanding
568.87M
No. of employees
4K
About Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CEO-
Employees3.89K
Founded1915
Headquarters-
SectorPharmaceutical industry
Websitejydrt.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.02B
1.25B
1.52B
939.39M
Cost of goods sold
238.27M
394.31M
337.79M
250.80M
Cost of revenue
238.27M
394.31M
337.79M
250.80M
Research and development expenses
43.07M
85.19M
29.81M
50.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514.66M
696.15M
625.03M
371.90M
Operating expense
563.62M
807.49M
677.84M
440.93M
Total operating expenses
801.90M
1.20B
1.02B
691.74M
Operating income
217.44M
45.67M
499.57M
-
Other non operating income
-2.64M
1.48M
-450.84K
-2.38M
EBT including unusual items
253.19M
-32.76M
494.29M
258.05M
EBT excluding unusual items
265.54M
66.32M
529.85M
264.05M
Income tax expense
30.06M
2.71M
71.23M
-
Effective tax rate
11.87%
-8.27%
14.41%
14.55%
Other operating expenses
5.74M
28.38M
20.68M
-
Net income
224.56M
-21.16M
423.80M
220.94M
Net profit margin
22.03%
-1.70%
27.97%
23.52%
Earnings per share
-
-
-
-
Interest and investment income
52.79M
22.29M
33.73M
20.96M
Interest expense
-2.01M
-2.32M
-3.00M
-
Net interest expenses
50.78M
19.97M
30.73M
18.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
247.23M
72.82M
526.71M
273.56M
Gain or loss from assets sale
74.81K
-2.83M
-
-594.94K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps